Censa Pharmaceuticals
Cambridge, US · Founded 2015 · Delaware corporation
Biotech
Founders & leadership
CS
Chris SchellingExecutive
JR
Jonathan ReisExecutive
Board
JB
Joseph BaronBoard director
Reported raises · per SEC filings
Form D private placements$3M disclosed across 2 rounds · 2016–2017
▶$1.5MraisedNov 2017 · 18 investors · PharmaceuticalsRule 506(b)
▶$1.5MraisedNov 2017 · 18 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Joseph BaronDirector
- Jonathan ReisExecutive Officer, Director
- Pini OrbachDirector
- Chris SchellingExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- Minimum investment
- $20K
- Proceeds to insiders
- $100K
- First sale
- Nov 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$1.5MraisedApr 2016 · 11 investors · PharmaceuticalsRule 506(b)
▶$1.5MraisedApr 2016 · 11 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Chris SchellingExecutive Officer, Director
- Jonathan ReisExecutive Officer, Director
- Joseph BaronDirector
- Offering amount
- $5M
- Amount sold
- $1.5M
- Minimum investment
- $20K
- Proceeds to insiders
- $400K
- First sale
- Apr 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 05, 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Censa Pharmaceuticals raised?
- Censa Pharmaceuticals has disclosed $3M raised across 2 rounds.
- Where is Censa Pharmaceuticals headquartered?
- Censa Pharmaceuticals is headquartered in Cambridge, US.